SurModics

About:

SurModics provides a surface modification and in vitro diagnostic technologies to the healthcare industry.

Website: http://www.surmodics.com/

Twitter/X: Surmodics

Top Investors: MidCap Financial

Description:

SurModics provides surface modification and in vitro diagnostic technologies to the healthcare industry. It also develops and commercializes highly differentiated vascular intervention medical devices designed to address unmet clinical needs and engineered to the most demanding requirements. This key growth strategy leverages the combination of the company’s expertise in proprietary surface modification and drug-delivery coating technologies, along with its device design, development, and manufacturing capabilities.

Total Funding Amount:

$125M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Eden Prairie, Minnesota, United States

Founded Date:

1979-01-01

Founders:

Number of Employees:

251-500

Last Funding Date:

2022-10-17

IPO Status:

Public

Industries:

© 2025 bioDAO.ai